Molecular Testing Improves Nodular Fasciitis Diagnosis - Takeaway - MDSpire
From the Journals

Molecular Testing Improves Nodular Fasciitis Diagnosis

USP6 analysis helps resolve uncertainty in atypical soft-tissue lesions

Share

  • 1

    USP6 rearrangements identified in 100% of nodular fasciitis cases.

  • 2

    66% of cases initially had no suspicion for the condition.

  • 3

    Molecular testing crucial for accurate diagnosis.

  • 4

    Five atypical cases presented in unusual locations.

  • 5

    Younger patients had atypical gene fusions.

  • 6

    Study underscores importance of histopathology and molecular testing combined.

Original Source(s)

Molecular Testing Improves Nodular Fasciitis Diagnosis

  • by Andrea Surnit

  • April 3, 2026

Related Content

Postmortem Blood Cultures May Aid Autopsy Analysis

Study examines bacterial findings in 100 medico-legal autopsies

  • April 8, 2026

  • 3 min
AI Tackles Pathology Report Complexity

A reasoning-based system aims to extract staging, histology, and biomarkers from narrative pathology reports

A Sharper Nanoscale View of Surface Molecules

Delay-controlled tip-enhanced sum frequency generation suppresses metallic background and reveals weak vibrational modes and molecular orientation

  • April 7, 2026

  • 2 min